Multicenter Nonrandomized Trial of Intravenous MERREM (Meropenem, ICI 194,660) for the Treatment of Hospital-Acquired Pneumonia

Study identifier:3591US/0020

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Multicenter Nonrandomized Trial of Intravenous MERREM (Meropenem, ICI 194,660) for the Treatment of Hospital-Acquired Pneumonia

Medical condition

infectious diseases

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Dec 1997
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria